398 related articles for article (PubMed ID: 9771768)
21. Botulinum toxin type F for treatment of dystonia: long-term experience.
Chen R; Karp BI; Hallett M
Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
23. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
[TBL] [Abstract][Full Text] [Related]
24. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
Tarsy D
Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
[TBL] [Abstract][Full Text] [Related]
25. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
[TBL] [Abstract][Full Text] [Related]
27. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
Samotus O; Lee J; Jog M
J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
[TBL] [Abstract][Full Text] [Related]
29. Selective peripheral denervation in patients with spasmodic torticollis.
Braun V; Richter HP
Stereotact Funct Neurosurg; 1991; 57(3):113-22. PubMed ID: 1819131
[TBL] [Abstract][Full Text] [Related]
30. [The clinical usefulness of botulinum toxin type A for spasmodic torticollis and facial spasm].
Mezaki T; Kaji R; Kimura J; Osame M; Mizuno Y; Hirayama K; Maruyama S; Iwata M; Kanazawa I; Kinoshita M
No To Shinkei; 1995 Aug; 47(8):749-54. PubMed ID: 7546919
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
32. Selective peripheral denervation for torticollis: preliminary results.
Davis DH; Ahlskog JE; Litchy WJ; Root LM
Mayo Clin Proc; 1991 Apr; 66(4):365-71. PubMed ID: 2013987
[TBL] [Abstract][Full Text] [Related]
33. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
Stefanoff P; Kiliszek M; Friedman A
Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
[TBL] [Abstract][Full Text] [Related]
34. [The phenomenology of cervical dystonia].
Reichel G; Stenner A; Jahn A
Fortschr Neurol Psychiatr; 2009 May; 77(5):272-7. PubMed ID: 19418385
[TBL] [Abstract][Full Text] [Related]
35. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic.
Cohen-Gadol AA; Ahlskog JE; Matsumoto JY; Swenson MA; McClelland RL; Davis DH
J Neurosurg; 2003 Jun; 98(6):1247-54. PubMed ID: 12816272
[TBL] [Abstract][Full Text] [Related]
36. Adult cases of congenital muscular torticollis successfully treated with botulinum toxin.
Bouchard M; Chouinard S; Suchowersky O
Mov Disord; 2010 Oct; 25(14):2453-6. PubMed ID: 20976740
[TBL] [Abstract][Full Text] [Related]
37. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
Dressler D; Kupsch A; Seitzinger A; Paus S
Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
[TBL] [Abstract][Full Text] [Related]
38. [Electromyography monitoring in the treatment of torticollis with botulinum toxin].
Domzał TM; Tutaj A
Pol Merkur Lekarski; 2000 Jul; 8(49):474-5. PubMed ID: 11070717
[TBL] [Abstract][Full Text] [Related]
39. Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia.
Dressler D; Paus S; Seitzinger A; Gebhardt B; Kupsch A
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1014-9. PubMed ID: 23687362
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of spasmodic torticollis by local injections of botulinum toxin].
Jedynak CP; de Saint Victor JF
Rev Neurol (Paris); 1990; 146(6-7):440-3. PubMed ID: 2399409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
